<DOC>
	<DOCNO>NCT02187523</DOCNO>
	<brief_summary>A study demonstrate bioequivalence telmisartan HCTZ administer fix dose combination comparison single unit formulation</brief_summary>
	<brief_title>Relative Oral Bioavailability Telmisartan / Hydrochlorothiazide ( HCTZ ) Fixed Dose Combination ( FDC ) Compared With Its Monocomponents Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Healthy subject determine result screen Signed write informed consent accordance good clinical practice ( GCP ) local legislation Age ≥ 18 ≤ 55 year Broca ≥ 20 % ≤ +20 % Any find medical examination ( include blood pressure , pulse rate electrocardiogram ( ECG ) ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Supine blood pressure screen systolic ≤ 110 mmHg diastolic ≤ 60 mmHg History orthostatic hypotension , fainting , spell blackout Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ≤ 1 month prior administration trial Use drug might influence result trial ( ≤ 10 day prior administration trial ) Participation another trial investigational drug ( ≤ 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke study day Alcohol abuse ( &gt; 60g/day ) Drug abuse Blood donation ( ≤ 1 month prior administration trial ) Excessive physical activity ( ≤ 5 day prior administration trial ) Any laboratory value outside reference range clinical relevance Hypersensitivity Telmisartan and/or HCTZ and/or related class drug For female subject : Pregnancy Positive pregnancy test No adequate contraception ( e.g . sterilization , intrauterine device ( IUD ) , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>